How does a patient’s personal situation affect CLL treatment choice?
UKALL60+: identifying the standard of care for elderly patients with ALL
Advancements in APL treatment: oral ATO, MRD and treatment objectives
MRD measurement: next-generation sequencing or flow cytometry?
Pembrolizumab consolidation therapy in multiple myeloma